Carbapenem-resistant Enterobacterales: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "== Management == * First-line includes meropenem-vaborbactam or ceftazidime-avibactam, directed by susceptibility resultsCiteRef:paul2022eu * For metallo-β-lactamases or extensively resistant bacteria, consider cefiderocol * For non-severe infections, consider aminoglycosides, including plazomicin; tigecycline would be second-line, though it can be considered in pneumonia Category:Antimicrobial resistance" |
(No difference)
|
Revision as of 02:26, 14 November 2024
Management
- First-line includes meropenem-vaborbactam or ceftazidime-avibactam, directed by susceptibility resultsCiteRef:paul2022eu
- For metallo-β-lactamases or extensively resistant bacteria, consider cefiderocol
- For non-severe infections, consider aminoglycosides, including plazomicin; tigecycline would be second-line, though it can be considered in pneumonia
